Charcot-Marie-Tooth disease: genes and variants
Charcot-Marie-Tooth disease is linked to 8 analyzed proteins (LMNA, MFN2, GJB1, PMP22, TTR, VCP, KIF5A and NTRK1). 304 DNA variants are known to cause it; 1,253 more are uncertain, and 27 of those already look disease-causing on computable evidence.
Last updated 2026-09-30. Research information, not medical advice.
Also known as: Charcot-Marie-Tooth disease type 1; Charcot-Marie-Tooth disease type 1A; Charcot-Marie-Tooth disease type 1E; Charcot-Marie-Tooth disease type 2; Charcot-Marie-Tooth disease type 2Y; Charcot-Marie-Tooth disease type 3; Charcot-Marie-Tooth disease X-linked dominant 1; Charcot-Marie-Tooth disease, type I; Charcot-Marie-Tooth disease, type IA
Genes linked to Charcot-Marie-Tooth disease
LMNA: Prelamin-A/C
The gene product produces lamins A and C, structural proteins that form the nuclear lamina beneath the inner nuclear membrane. Lamins help maintain nuclear shape and organize chromatin, and LMNA variants are associated with muscular dystrophy, cardiomyopathy, lipodystrophy, and premature-aging syndromes.
130 disease-causing and 502 uncertain variants in LMNA are linked to Charcot-Marie-Tooth disease.
MFN2: Mitofusin-2
It promotes outer-mitochondrial-membrane fusion and coordinates mitochondrial transport, distribution, and contacts with other organelles. Pathogenic variants are a major cause of Charcot-Marie-Tooth disease type 2A and related axonal neuropathies.
86 disease-causing and 480 uncertain variants in MFN2 are linked to Charcot-Marie-Tooth disease.
GJB1: Gap junction beta-1 protein
It forms connexin 32 channels that support metabolic and signaling communication across layers of peripheral myelin produced by Schwann cells. Pathogenic variants cause X-linked Charcot-Marie-Tooth disease type 1, often with transient central nervous system manifestations in some individuals.
54 disease-causing and 155 uncertain variants in GJB1 are linked to Charcot-Marie-Tooth disease.
PMP22: Peripheral myelin protein 22
Its dosage is critical for normal Schwann-cell myelin formation and stability in peripheral nerves. Duplication causes Charcot-Marie-Tooth disease type 1A, deletion causes hereditary neuropathy with liability to pressure palsies, and point variants cause additional neuropathies.
28 disease-causing and 87 uncertain variants in PMP22 are linked to Charcot-Marie-Tooth disease.
TTR: Transthyretin
Its tetramer transports thyroxine and retinol-binding protein, but destabilization can expose aggregation-prone monomers. Pathogenic variants cause hereditary transthyretin amyloidosis affecting peripheral nerves and heart, while wild-type protein can also form cardiac amyloid with aging.
3 disease-causing and 5 uncertain variants in TTR are linked to Charcot-Marie-Tooth disease.
VCP: Transitional endoplasmic reticulum ATPase
It uses ATP to extract ubiquitinated proteins from complexes or membranes for recycling or degradation and is central to proteostasis, ER-associated degradation, and autophagy. Dominant pathogenic variants cause multisystem proteinopathy with inclusion-body myopathy, Paget disease, frontotemporal dementia, or ALS.
2 disease-causing and 2 uncertain variants in VCP are linked to Charcot-Marie-Tooth disease.
KIF5A: Kinesin heavy chain isoform 5A
It drives anterograde transport of organelles and proteins along axonal microtubules and is especially important in long motor neurons. Pathogenic variants can cause hereditary spastic paraplegia, axonal Charcot-Marie-Tooth disease, or amyotrophic lateral sclerosis depending on the affected region and mechanism.
1 disease-causing and 0 uncertain variants in KIF5A are linked to Charcot-Marie-Tooth disease.
NTRK1: High affinity nerve growth factor receptor
Nerve-growth-factor signaling through this pathway supports survival and differentiation of sensory and sympathetic neurons. Loss-of-function variants cause congenital insensitivity to pain with anhidrosis, whereas oncogenic NTRK1 fusions can drive diverse cancers.
0 disease-causing and 8 uncertain variants in NTRK1 are linked to Charcot-Marie-Tooth disease.
Weakly linked (only a few uncertain records): SETX, POLG, DNMT1, ATP7A, COL6A2, GABRG2, GLA and LAMA2.
Where Charcot-Marie-Tooth disease variants cluster
- MFN2 Dynamin-type G (positions 93–342): 57 of 86 disease-causing changes, 2.0× more than its size predicts.
- LMNA Coil 1A (positions 34–70): 23 of 130 disease-causing changes, 3.2× more than its size predicts.
- MFN2 Part of a helix bundle domain, formed by helices (positions 359–385): 12 of 86 disease-causing changes, 3.9× more than its size predicts.
- GJB1 Extracellular (positions 154–191): 16 of 54 disease-causing changes, 2.2× more than its size predicts.
- LMNA Head (positions 1–33): 15 of 130 disease-causing changes, 2.3× more than its size predicts.
Known disease-causing variants in Charcot-Marie-Tooth disease
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| MFN2 A738V | 738 | Coiled coil | Disease-causing (★★★★) |
| PMP22 T23R | 23 | Transmembrane | Disease-causing (★★) |
| GJB1 R15Q | 15 | Cytoplasmic | Disease-causing (★★) |
| GJB1 R164W | 164 | Extracellular | Disease-causing (★★) |
| GJB1 R183C | 183 | Extracellular | Disease-causing (★★) |
| GJB1 R183H | 183 | Extracellular | Disease-causing (★★) |
| GJB1 R183S | 183 | Extracellular | Disease-causing (★★) |
| LMNA R25G | 25 | Head | Disease-causing (★★) |
| LMNA R25C | 25 | Head | Disease-causing (★★) |
| LMNA R25H | 25 | Head | Disease-causing (★★) |
| LMNA R28W | 28 | Head | Disease-causing (★★) |
| LMNA N39D | 39 | IF rod | Disease-causing (★★) |
| LMNA N39S | 39 | IF rod | Disease-causing (★★) |
| LMNA R41H | 41 | IF rod | Disease-causing (★★) |
| LMNA R62C | 62 | IF rod | Disease-causing (★★) |
| LMNA L92F | 92 | IF rod | Disease-causing (★★) |
| LMNA R190Q | 190 | IF rod | Disease-causing (★★) |
| LMNA R190W | 190 | IF rod | Disease-causing (★★) |
| LMNA R453W | 453 | LTD | Disease-causing (★★) |
| LMNA R541C | 541 | LTD | Disease-causing (★★) |
| LMNA R541H | 541 | LTD | Disease-causing (★★) |
| LMNA R541S | 541 | LTD | Disease-causing (★★) |
| MFN2 R259C | 259 | Dynamin-type G | Disease-causing (★★) |
| MFN2 R259L | 259 | Dynamin-type G | Disease-causing (★★) |
| PMP22 H12Q | 12 | Transmembrane | Disease-causing (★★) |
| PMP22 H12R | 12 | Transmembrane | Disease-causing (★★) |
| PMP22 T23K | 23 | Transmembrane | Disease-causing (★★) |
| PMP22 M69K | 69 | Transmembrane | Disease-causing (★★) |
| PMP22 S72L | 72 | Transmembrane | Disease-causing (★★) |
| PMP22 S72W | 72 | Transmembrane | Disease-causing (★★) |
| PMP22 S79T | 79 | Transmembrane | Disease-causing (★★) |
| PMP22 G150D | 150 | Transmembrane | Disease-causing (★★) |
| PMP22 G150V | 150 | Transmembrane | Disease-causing (★★) |
| PMP22 G150C | 150 | Transmembrane | Disease-causing (★★) |
| PMP22 G150R | 150 | Transmembrane | Disease-causing (★★) |
| LMNA M1I | 1 | Head | Disease-causing (★★) |
| LMNA R28Q | 28 | Head | Disease-causing (★★) |
| LMNA E31K | 31 | IF rod | Disease-causing (★★) |
| LMNA K32E | 32 | IF rod | Disease-causing (★★) |
| LMNA R48P | 48 | IF rod | Disease-causing (★★) |
| LMNA R62G | 62 | IF rod | Disease-causing (★★) |
| LMNA E65G | 65 | IF rod | Disease-causing (★★) |
| LMNA E82K | 82 | IF rod | Disease-causing (★★) |
| LMNA R89L | 89 | IF rod | Disease-causing (★★) |
| LMNA E203K | 203 | IF rod | Disease-causing (★★) |
| LMNA E203V | 203 | IF rod | Disease-causing (★★) |
| LMNA E203G | 203 | IF rod | Disease-causing (★★) |
| LMNA E372D | 372 | IF rod | Disease-causing (★★) |
| LMNA E383K | 383 | IF rod | Disease-causing (★★) |
| LMNA R386K | 386 | IF rod | Disease-causing (★★) |
| LMNA N456D | 456 | LTD | Disease-causing (★★) |
| LMNA T528K | 528 | LTD | Disease-causing (★★) |
| LMNA T528R | 528 | LTD | Disease-causing (★★) |
| LMNA T528P | 528 | LTD | Disease-causing (★★) |
| MFN2 I88T | 88 | Part of a helix bundle domain, formed by helices | Disease-causing (★★) |
| MFN2 R94G | 94 | Dynamin-type G | Disease-causing (★★) |
| MFN2 R94W | 94 | Dynamin-type G | Disease-causing (★★) |
| MFN2 T105M | 105 | Dynamin-type G | Disease-causing (★★) |
| MFN2 H165R | 165 | Dynamin-type G | Disease-causing (★★) |
| MFN2 H165Y | 165 | Dynamin-type G | Disease-causing (★★) |
Showing 60 of 304.
Uncertain variants in Charcot-Marie-Tooth disease that look disease-causing
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| PMP22 R157Q | 157 | Cytoplasmic | Uncertain (★) | +7: in a 3D region that tolerates change poorly (1R); R157W at the same position is pathogenic; seen in 3.4e-06 of gnomAD DNA copies; REVEL 0.924 |
| PMP22 T23M | 23 | Transmembrane | Uncertain (★★) | +7: 3 other pathogenic changes within 3 positions; T23K at the same position is pathogenic; seen in 6.6e-06 of gnomAD DNA copies; REVEL 0.802 |
| LMNA R41L | 41 | IF rod | Conflicting reports (★) | +6: 10 other pathogenic changes within 3 positions; R41C at the same position is pathogenic; REVEL 0.970 |
| LMNA A43T | 43 | IF rod | Conflicting reports (★) | +6: 4 other pathogenic changes within 3 positions; A43E at the same position is pathogenic; REVEL 0.966 |
| PMP22 M69T | 69 | Transmembrane | Conflicting reports (★) | +6: 6 other pathogenic changes within 3 positions; M69K at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.98 |
| MFN2 R259H | 259 | Dynamin-type G | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; R259S at the same position is pathogenic; REVEL 0.959 |
| LMNA T528M | 528 | LTD | Conflicting reports (★) | +6: 6 other pathogenic changes within 3 positions; T528K at the same position is pathogenic; REVEL 0.889 |
| LMNA D446G | 446 | LTD | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; D446V at the same position is pathogenic; REVEL 0.981 |
| LMNA R89H | 89 | IF rod | Conflicting reports (★) | +6: 4 other pathogenic changes within 3 positions; R89G at the same position is pathogenic; REVEL 0.911 |
| PMP22 A67T | 67 | Transmembrane | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; A67P at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99 |
| LMNA R527C | 527 | LTD | Conflicting reports (★) | +6: 6 other pathogenic changes within 3 positions; R527P at the same position is pathogenic; REVEL 0.862 |
| LMNA N456S | 456 | LTD | Conflicting reports (★) | +6: 7 other pathogenic changes within 3 positions; N456K at the same position is pathogenic; REVEL 0.923 |
| LMNA R41S | 41 | IF rod | Conflicting reports (★) | +6: 10 other pathogenic changes within 3 positions; R41C at the same position is pathogenic; REVEL 0.924 |
| LMNA R527L | 527 | LTD | Conflicting reports (★) | +6: 6 other pathogenic changes within 3 positions; R527P at the same position is pathogenic; REVEL 0.785 |
| LMNA L92V | 92 | IF rod | Conflicting reports (★) | +6: 5 other pathogenic changes within 3 positions; L92P at the same position is pathogenic; REVEL 0.776 |
| LMNA A278T | 278 | IF rod | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; A278P at the same position is pathogenic; REVEL 0.780 |
| MFN2 M234V | 234 | Dynamin-type G | Conflicting reports (★) | +6: 5 other pathogenic changes within 3 positions; M234L at the same position is pathogenic; REVEL 0.781 |
| MFN2 I255M | 255 | Dynamin-type G | Conflicting reports (★) | +6: in a 3D region that tolerates change poorly (3R); I255T at the same position is pathogenic; REVEL 0.825 |
| PMP22 R157G | 157 | Cytoplasmic | Uncertain | +6: in a 3D region that tolerates change poorly (1R); R157W at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.90 |
| MFN2 V273M | 273 | Dynamin-type G | Uncertain (★★) | +6: 3 other pathogenic changes within 3 positions; V273G at the same position is pathogenic; REVEL 0.914 |
| PMP22 L147R | 147 | Transmembrane | Uncertain | +6: 8 other pathogenic changes within 3 positions; L147P at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.97 |
| LMNA A375T | 375 | IF rod | Uncertain (★★) | +6: 7 other pathogenic changes within 3 positions; A375G at the same position is pathogenic; REVEL 0.811 |
| LMNA Q198K | 198 | IF rod | Uncertain (★) | +6: 3 other pathogenic changes within 3 positions; Q198P at the same position is pathogenic; REVEL 0.816 |
| GJB1 C173R | 173 | Extracellular | Uncertain | +6: 3 other pathogenic changes within 3 positions; C173F at the same position is pathogenic; REVEL 0.974 |
| PMP22 S22Y | 22 | Transmembrane | Uncertain (★★) | +6: 3 other pathogenic changes within 3 positions; S22F at the same position is pathogenic; seen in 0 of gnomAD DNA copies; REVEL 0.735 |
| LMNA R455C | 455 | LTD | Uncertain (★★) | +6: 7 other pathogenic changes within 3 positions; R455P at the same position is pathogenic; REVEL 0.804 |
| PMP22 S22P | 22 | Transmembrane | Uncertain (★) | +6: 3 other pathogenic changes within 3 positions; S22F at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.61 |
Which prediction tools work for Charcot-Marie-Tooth disease
How often each tool ranks a disease-causing variant above a harmless one (AUROC × 100).
- CATVariant: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 94 out of 100
- CADD: 92 out of 100
- MetaLR: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred2: 89 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- EVE: 87 out of 100
- PolyPhen-2: 85 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 84 out of 100
- phyloP: 83 out of 100
Same protein, different disease
- Dilated cardiomyopathy is also caused by LMNA variants; they fall in the same places as the Charcot-Marie-Tooth disease variants (21 disease-causing).
- Familial partial lipodystrophy, Dunnigan type is also caused by LMNA variants; they fall in the same places as the Charcot-Marie-Tooth disease variants (13 disease-causing).
- Emery-Dreifuss muscular dystrophy is also caused by LMNA variants; they fall in the same places as the Charcot-Marie-Tooth disease variants (12 disease-causing).
- Congenital muscular dystrophy due to LMNA mutation is also caused by LMNA variants; they fall in the same places as the Charcot-Marie-Tooth disease variants (11 disease-causing).
- Hutchinson-Gilford syndrome is also caused by LMNA variants; they fall partly in the same places as the Charcot-Marie-Tooth disease variants (9 disease-causing).
- Charcot-Marie-Tooth disease type 2A2 is also caused by MFN2 variants; they fall partly in the same places as the Charcot-Marie-Tooth disease variants (32 disease-causing).
- Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b; is also caused by MFN2 variants; they fall in the same places as the Charcot-Marie-Tooth disease variants (9 disease-causing).
- Charcot-Marie-Tooth Neuropathy X is also caused by GJB1 variants; they fall in the same places as the Charcot-Marie-Tooth disease variants (90 disease-causing).
- Amyloidosis, hereditary systemic 1 is also caused by TTR variants; they fall mostly in different places as the Charcot-Marie-Tooth disease variants (101 disease-causing).
- Carpal tunnel syndrome is also caused by TTR variants; they fall mostly in different places as the Charcot-Marie-Tooth disease variants (8 disease-causing).
- Hyperthyroxinemia, dystransthyretinemic is also caused by TTR variants; they fall mostly in different places as the Charcot-Marie-Tooth disease variants (7 disease-causing).
- Inclusion body myopathy with Paget disease of bone and frontotemporal dementia is also caused by VCP variants; they fall mostly in different places as the Charcot-Marie-Tooth disease variants (31 disease-causing).
- Frontotemporal dementia and/or amyotrophic lateral sclerosis is also caused by VCP variants; they fall mostly in different places as the Charcot-Marie-Tooth disease variants (30 disease-causing).
- Childhood Onset VCP-related Neurodevelopmental Disorder is also caused by VCP variants; they fall mostly in different places as the Charcot-Marie-Tooth disease variants (4 disease-causing).
Diseases related to Charcot-Marie-Tooth disease
- Peripheral neuropathy, also linked to GJB1, KIF5A and MFN2
- Amyotrophic lateral sclerosis, also linked to KIF5A and VCP
- Auditory neuropathy, also linked to KIF5A and MFN2
- Hereditary spastic paraplegia, also linked to KIF5A
- Alzheimer disease, also linked to VCP
- Dilated cardiomyopathy, also linked to LMNA
- Amyloidosis, hereditary systemic 1, also linked to TTR
- Bethlem myopathy, also linked to LMNA
- Charcot-Marie-Tooth Neuropathy X, also linked to GJB1
- Primary dilated cardiomyopathy, also linked to LMNA
- Ovarian cancer, also linked to NTRK1
- Frontotemporal dementia and/or amyotrophic lateral sclerosis, also linked to VCP
Frequently asked questions
Which genes are linked to Charcot-Marie-Tooth disease?
In CATVariant, Charcot-Marie-Tooth disease is linked to 8 analyzed proteins: LMNA (Prelamin-A/C), MFN2 (Mitofusin-2), GJB1 (Gap junction beta-1 protein), PMP22 (Peripheral myelin protein 22), TTR (Transthyretin), VCP (Transitional endoplasmic reticulum ATPase) and 2 more.
How many genetic variants are linked to Charcot-Marie-Tooth disease?
1,711 variants: 304 are classified as disease-causing (pathogenic or likely pathogenic) in ClinVar and 1,253 are of uncertain significance or have conflicting reports.
Which uncertain variants in Charcot-Marie-Tooth disease look disease-causing?
27 uncertain variants reach the likely-pathogenic range of the ACMG/AMP points scale on computable evidence, for example PMP22 R157Q, PMP22 T23M, LMNA R41L, LMNA A43T and PMP22 M69T. These are leads for expert review, not diagnoses.
Which variant effect predictor works best for Charcot-Marie-Tooth disease?
Among tools not trained on clinical labels, AlphaMissense separates this disease's known disease-causing variants from harmless ones best (AUROC 0.94, based on 231 disease-causing and 80 harmless variants).
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from the latest public CATVariant analysis of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center